You have no items in your shopping cart.
Human DES1-3 IGF-I [orb3002343]SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 7.3 KDa. Observed: 9 KDa, reducing conditions
10 μg, 50 μg, 1 mg, 500 μg- Mouse IGFBP-6 [orb3002294]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 23.7 KDa. Observed: 28 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Mouse IGFBP-7 [orb3002302]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 27.2 KDa. Observed: 32-35 KDa, reducing conditions
1 mg, 10 μg, 50 μg, 500 μg - Human IGFBP-1 [orb3002307]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 26.1 KDa. Observed: 30-35 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Mouse LR3-IGF-1 [orb3002317]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 10.2 KDa. Observed: 12 KDa, reducing conditions
1 mg, 10 μg, 50 μg, 500 μg - Human IGFBP-7 [orb3002323]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 27.3 KDa. Observed: 30-35 KDa, reducing conditions
10 μg, 50 μg, 1 mg, 500 μg - Mouse IGFBP-5 [orb3002276]
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 29.3 KDa. Observed: 38 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human LR3-IGF-1 [orb3002469]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 9.1 KDa. Observed: 11 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human IGFBP-4 [orb3002279]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 27.01 KDa. Observed: 30-35 KDa, reducing conditions
10 μg, 500 μg, 1 mg, 50 μg